168.05M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Similar securities

Based on sector and market capitalization

Report issue